Comparison of the Effectiveness of Paracetamol and Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial.

IF 2.4 Q1 PEDIATRICS
S Mohsin Ali Shah, Shaista Azeem Khan, Faran Sadiq, Ruba Gul, Faizan Sadiq, Misbah Ullah Khan, Muhammad Khalid Khan, Faryal Uzma, Arooj Khan, Sabir Khan
{"title":"Comparison of the Effectiveness of Paracetamol and Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial.","authors":"S Mohsin Ali Shah, Shaista Azeem Khan, Faran Sadiq, Ruba Gul, Faizan Sadiq, Misbah Ullah Khan, Muhammad Khalid Khan, Faryal Uzma, Arooj Khan, Sabir Khan","doi":"10.1186/s40348-025-00189-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patent ductus arteriosus is one of the most common cardiac conditions affecting the neonates. Considering the lack of studies done on this topic in healthcare settings in Khyber Pakhtunkhwa province, this study aims to find out the comparative effectiveness of paracetamol and ibuprofen in management of PDA in our healthcare setting to conclude a better management option for the condition.</p><p><strong>Objective: </strong>To find and compare the effectiveness of paracetamol and ibuprofen in the closure of patent ductus arteriosus in preterm neonates.</p><p><strong>Methodology: </strong>This randomized controlled trial was conducted in the Department of Nursery and Neonatal Intensive Care Unit, Khyber Teaching Hospital, Peshawar, Pakistan, from 10th April 2024 to 10th October 2024. A total of 256 neonates of both genders with patent ductus arteriosus were included. Group A received oral paracetamol, and Group B received oral ibuprofen. The effectiveness of the treatments was evaluated at the end of the treatment period.</p><p><strong>Results: </strong>The age range in this study was from 48 to 96 h, with a mean age of 71.79 ± 13.10 h in Group A and 73.40 ± 11.81 h in Group B. Efficacy was observed in 107 (83.6%) patients in Group A compared to 90 (70.3%) patients in Group B, showing a statistically significant difference (P = 0.011).</p><p><strong>Conclusion: </strong>Our study has concluded that paracetamol is more effective than ibuprofen in closing patent ductus arteriosus. The trials were retrospectively registered at NIH Trial Registry (NCT06601114) https://clinicaltrials.gov/study/NCT06601114 dated 15/09/2024.</p>","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":"12 1","pages":"2"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11762024/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and cellular pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40348-025-00189-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patent ductus arteriosus is one of the most common cardiac conditions affecting the neonates. Considering the lack of studies done on this topic in healthcare settings in Khyber Pakhtunkhwa province, this study aims to find out the comparative effectiveness of paracetamol and ibuprofen in management of PDA in our healthcare setting to conclude a better management option for the condition.

Objective: To find and compare the effectiveness of paracetamol and ibuprofen in the closure of patent ductus arteriosus in preterm neonates.

Methodology: This randomized controlled trial was conducted in the Department of Nursery and Neonatal Intensive Care Unit, Khyber Teaching Hospital, Peshawar, Pakistan, from 10th April 2024 to 10th October 2024. A total of 256 neonates of both genders with patent ductus arteriosus were included. Group A received oral paracetamol, and Group B received oral ibuprofen. The effectiveness of the treatments was evaluated at the end of the treatment period.

Results: The age range in this study was from 48 to 96 h, with a mean age of 71.79 ± 13.10 h in Group A and 73.40 ± 11.81 h in Group B. Efficacy was observed in 107 (83.6%) patients in Group A compared to 90 (70.3%) patients in Group B, showing a statistically significant difference (P = 0.011).

Conclusion: Our study has concluded that paracetamol is more effective than ibuprofen in closing patent ductus arteriosus. The trials were retrospectively registered at NIH Trial Registry (NCT06601114) https://clinicaltrials.gov/study/NCT06601114 dated 15/09/2024.

对乙酰氨基酚与布洛芬治疗早产儿动脉导管未闭的疗效比较:一项随机对照试验。
背景:动脉导管未闭是影响新生儿最常见的心脏疾病之一。考虑到在开伯尔-普赫图赫瓦省的医疗机构中缺乏关于这一主题的研究,本研究旨在找出扑热息痛和布洛芬在我们的医疗机构中管理PDA的比较有效性,以得出更好的管理方案。目的:观察并比较扑热息痛与布洛芬在早产儿动脉导管未闭闭合中的疗效。方法:该随机对照试验于2024年4月10日至2024年10月10日在巴基斯坦白沙瓦开伯尔教学医院托儿所和新生儿重症监护室进行。本研究共纳入256名男女动脉导管未闭新生儿。A组口服扑热息痛,B组口服布洛芬。在治疗期结束时评估治疗的有效性。结果:本研究患者年龄范围为48 ~ 96 h, a组平均年龄为71.79±13.10 h, B组平均年龄为73.40±11.81 h。a组107例(83.6%)患者疗效显著,B组90例(70.3%)患者疗效显著,差异有统计学意义(P = 0.011)。结论:对乙酰氨基酚治疗动脉导管未闭的疗效优于布洛芬。这些试验回顾性地登记在NIH试验登记处(NCT06601114) https://clinicaltrials.gov/study/NCT06601114,日期为15/09/2024。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信